Irf8 exacerbates hypertensive intracerebral hemorrhage by mediating a pro-inflammatory phenotype of microglia through

Jingkun Wu1, Liang Hou1, Qinghua Zhu1

  • 1Department 2 of Neurosurgery, Affiliated Hospital of Hebei University of Engineering, Handan 056000, Hebei, PR China.

PubMed

Insights

Interferon regulatory factor 8 (Irf8) drives microglial inflammation in hypertensive intracerebral hemorrhage (ICH). Downregulating Irf8 reduces inflammation and neurological deficits, suggesting Irf8 as a therapeutic target for ICH.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Microglia are key immune cells in the brain.
  • Interferon regulatory factor 8 (Irf8) is a transcription factor critical for microglial function.
  • Hypertensive intracerebral hemorrhage (ICH) involves significant neuroinflammation.

Purpose of the Study:

  • To investigate the role of Irf8 in microglial activation during hypertensive ICH.
  • To elucidate the molecular mechanisms by which Irf8 influences neuroinflammation in ICH.

Main Methods:

  • Established a mouse model of ICH using L-NAME and angiotensin II.
  • Utilized stereotactic injections of knockdown and overexpression vectors for Irf8.
  • Induced inflammatory responses in BV-2 microglial cells with LPS and manipulated gene expression via lentiviral infection.

Main Results:

  • Irf8 was significantly overexpressed in ICH mouse brains and LPS-stimulated BV-2 cells.
  • Irf8 downregulation reduced M1 microglial polarization, inflammation, and neurological deficits in ICH mice.
  • Irf8 was found to interact with Stat1, mediating the transcriptional activation of Trim5, and this axis exacerbated ICH.

Conclusions:

  • Irf8 overexpression promotes a pro-inflammatory microglial phenotype in ICH.
  • The Irf8-Stat1-Trim5 axis plays a crucial role in exacerbating hypertensive ICH.
  • Targeting Irf8 may offer a therapeutic strategy for mitigating ICH progression.